"You do have to wonder if MSB had only taken one application and gone with a purely AU focused trial and regulatory pathway if it would not have done better?"
Absolutely! Focus on one indication and get it over the line. Build not only revenue but also investor confidence.
And for MSB the missed opportunity was long bone fractures - a long time ago, but incredible efficacy as those of us who invested in the IPO will remember. Small market yes, but clear path to approval and launch other programs off that.
Would be interesting to compile a list of all the fantastic opportunities this company has explored/touted over the years - long bone, cord blood, diabetes, MS, neurological (originally part of the Cephalon deal, what happened to that?), heart, spine, COVID, GvHD and no doubt there's many I have forgotten.
When you spread yourself so thinly, it's no wonder nothing is pursued all the way through to success.
Unfortunately, an affliction of the biotech scene in this country - always need another opportunity to deflect attention - "look over here!". And MSB is by no means the worst - in comparison to some others it doesn't come out all that bad.
- Forums
- ASX - By Stock
- banter and General Discussion
"You do have to wonder if MSB had only taken one application and...
-
-
- There are more pages in this discussion • 1,742 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B |
Open | High | Low | Value | Volume |
95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 72752 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 205100 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.005 |
5 | 57985 | 1.000 |
1 | 50000 | 0.995 |
2 | 20525 | 0.990 |
1 | 10000 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.035 | 190122 | 7 |
1.045 | 39714 | 5 |
1.050 | 21696 | 6 |
1.060 | 9750 | 2 |
1.065 | 5780 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online